TITLE

HIV-2 viral tropism influences CD4+ T cell count regardless of viral load

AUTHOR(S)
Treviño, Ana; Soriano, Vicente; Poveda, Eva; Parra, Patricia; Cabezas, Teresa; Caballero, Estrella; Roc, Lourdes; Rodríguez, Carmen; Eiros, Jose M.; Lopez, Mariola; De Mendoza, Carmen
PUB. DATE
August 2014
SOURCE
Journal of Antimicrobial Chemotherapy (JAC);Aug2014, Vol. 69 Issue 8, p2191
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background HIV-2 infection is characterized by low plasma viraemia and slower progression to AIDS in comparison with HIV-1 infection. However, antiretroviral therapy in patients with HIV-2 is less effective and often fails to provide optimal CD4 recovery. Methods We examined viral tropism in persons with HIV-2 infection enrolled in the HIV-2 Spanish cohort. Viral tropism was estimated based on V3 sequences obtained from plasma RNA and/or proviral DNA. Results From a total of 279 individuals with HIV-2 infection recorded in the Spanish national register, 58 V3 sequences belonging to 42 individuals were evaluated. X4 viruses were recognized in 14 patients (33%). Patients with X4 viruses had lower median CD4+ cell counts than patients with R5 viruses [130 (17–210) versus 359 (180–470) cells/mm3; P = 0.007]. This was true even considering only the subset of 19 patients on antiretroviral therapy [94 (16–147) versus 184 (43–368) cells/mm3; P = 0.041]. In multivariate analysis, significant differences in CD4+ cell counts between patients with X4 and R5 viruses remained after adjusting for age, gender, antiretroviral therapy and viral load. Conclusions The presence of X4-tropic viruses in HIV-2 infection is associated with low CD4+ cell counts, regardless of antiretroviral treatment. Along with CD4+ cell counts, viral tropism testing may assist decisions about when to initiate antiretroviral therapy in HIV-2-infected individuals.
ACCESSION #
97238874

 

Related Articles

  • Interleukin 2 treatment for HIV infection. Blankson, Joel; Siliciano, Robert F.; Blankson, J; Siliciano, R F // JAMA: Journal of the American Medical Association;7/12/2000, Vol. 284 Issue 2, p236 

    Editorial. Discusses the disadvantages associated with the use of highly active antiretroviral therapy (HAART) for the treatment of HIV. Challenges to the patient; Complexity and toxicity of the regimen; Rationale for the use of interleukin-2 in HIV-1 infection; Mention of two articles in this...

  • Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe. Schomaker, Michael; Leroy, Valeriane; Wolfs, Tom; Technau, Karl-Günter; Renner, Lorna; Judd, Ali; Sawry, Shobna; Amorissani-Folquet, Madeleine; Noguera-Julian, Antoni; Tanser, Frank; Eboua, François; Navarro, Maria Luisa; Chimbetete, Cleophas; Amani-Bosse, Clarisse; Warszawski, Josiane; Phiri, Sam; N'Gbeche, Sylvie; Cox, Vivian; Koueta, Fla; Giddy, Janet // International Journal of Epidemiology;Apr2017, Vol. 46 Issue 2, p453 

    Background: There is limited knowledge about the optimal timing of antiretroviral treatment initiation in older children and adolescents.Methods: A total of 20 576 antiretroviral treatment (ART)-naïve patients, aged 1-16 years at enrolment, from 19 cohorts in...

  • Global Response to HIV: Treatment as Prevention, or Treatment for Treatment? Sigaloff, Kim C. E.; Lange, Joep M. A.; Montaner, Julio // Clinical Infectious Diseases;Jul2014, Vol. 59 Issue suppl_1, pS7 

    The concept of “treatment as prevention” has emerged as a means to curb the global HIV epidemic. There is, however, still ongoing debate about the evidence on when to start antiretroviral therapy in resource-poor settings. Critics have brought forward multiple arguments against a...

  • Efficacy and Safety of Emtricitabine vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients: A Randomized Trial. Saag, Michael S.; Cahn, Pedro; Raffi, François; Wolff, Marcelo; Pearce, Daniel; Molina, Jean-Michel; Powderly, William; Shaw, Audrey L.; Mondou, Elsa; Hinkle, John; Borroto-Esoda, Katyna; Quinn, Joseph B.; Barry, David W.; Rousseau, Franck // JAMA: Journal of the American Medical Association;7/14/2004, Vol. 292 Issue 2, p180 

    Context Emtricitabine is a new, once-daily nucleoside reverse transcriptase inhibitor (NRTI) with potent activity against human immunodeficiency virus (HIV). Objective To assess the efficacy and safety of emtricitabine as compared with stavudine when used with a background regimen of didanosine...

  • Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients: A 3-Year Randomized Trial. Gallant, Joel E.; Staszewski, Schlomo; Pozniak, Anton L.; DeJesus, Edwin; Suleiman, Jamal M. A. H.; Miller, Michael D.; Coakley, Dion F.; Lu, Biao; Toole, John J.; Cheng, Andrew K. // JAMA: Journal of the American Medical Association;7/14/2004, Vol. 292 Issue 2, p191 

    Context Tenofovir disoproxil fumarate (DF) is a once-daily nucleotide analogue reverse transcriptase inhibitor. Objective To evaluate the efficacy and safety of tenofovir DF compared with stavudine in antiretroviral-naive patients. Design, Setting, and Participants A prospective, randomized,...

  • Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis Suthar, Amitabh B.; Lawn, Stephen D.; del Amo, Julia; Getahun, Haileyesus; Dye, Christopher; Sculier, Delphine; Sterling, Timothy R.; Chaisson, Richard E.; Williams, Brian G.; Harries, Anthony D.; Granich, Reuben M. // PLoS Clinical Trials;Jul2012, Vol. 7 Issue 7, p1 

    In a systematic review and meta-analysis, Amitabh Suthar and colleagues investigate the association between antiretroviral therapy and the reduction in the incidence of tuberculosis in adults with HIV infection.

  • The development of drug resistance mutations K103N Y181C and G190A in long term Nevirapine-containing antiviral therapy. Yuncong Wang; Hui Xing; Lingjie Liao; Zhe Wang; Bin Su; Quanbi Zhao; Yi Feng; Pengfei Ma; Jia Liu; Jianjun Wu; Yuhua Ruan; Yiming Shao // AIDS Research & Therapy;2014, Vol. 11, p1 

    Objective We built a cohort study of HIV patients taking long-term first-line Antiretroviral Therapy in 2003. In this assay, we focused on the development of primary drug resistance mutations against Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), K103N, Y181C and G190A. Method The...

  • Non-physician clinician provided HIV treatment results in equivalent outcomes as physician-provided care: a meta-analysis. Emdin, Connor A; Chong, Nicholas J; Millson, Peggy E // Journal of the International AIDS Society;2013, Vol. 16 Issue 1, p1 

    Introduction: A severe healthcare worker shortage in sub-Saharan Africa is inhibiting the expansion of HIV treatment. Task shifting, the transfer of antiretroviral therapy (ART) management and initiation from doctors to nurses and other non-physician clinicians, has been proposed to address this...

  • Hepatitis B and C Co-Infection among HIV-Infected Adults while on Antiretroviral Treatment: Long-Term Survival, CD4 Cell Count Recovery and Antiretroviral Toxicity in Cambodia. van Griensven, Johan; Phirum, Lay; Choun, Kimcheng; Thai, Sopheak; De Weggheleire, Anja; Lynen, Lutgarde // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    Background: Despite the high burden, there is a dearth of (long-term) outcome data of hepatitis B virus (HBV) and hepatitis C virus (HCV) co-infected patients receiving antiretroviral treatment (ART) in a clinical setting in resource-constrained settings, particularly from Asia. Methods: We...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics